Back | Next |
home / stock / xsnx / xsnx message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $XSNX News Article - NovAccess Global Announces Filing of Orphan Drug Application for T | whytestocks | investorshangout | 07/19/2022 4:52:14 PM |
NovAccess Global Announces Filing of Orphan Drug Application | BooDog | investorshub | 07/19/2022 4:35:19 PM |
Makes one wonder. And I didn't even watch | BooDog | investorshub | 06/09/2022 10:08:40 PM |
A 47% day. Hmmmmm | BooDog | investorshub | 02/09/2022 9:43:16 PM |
On December 30, 2021, NovAccess Global Inc. (NovAccess | BooDog | investorshub | 01/05/2022 7:57:24 PM |
See yesterday's 8k. 25k for 10% interest per | BooDog | investorshub | 01/05/2022 6:29:35 PM |
Yes, I'm still here. | BooDog | investorshub | 12/29/2021 4:33:16 PM |
Guess we'll wait for the penny. Or lower. | BooDog | investorshub | 12/21/2021 8:51:45 PM |
NovAccess Global, Inc. Names Neil Laird, Chief Financial Officer | BooDog | investorshub | 12/08/2021 4:43:02 PM |
My new otc pick. $XSNX. Watching to see | BooDog | investorshub | 11/11/2021 10:07:51 PM |
Board marked. I know they're trying to get | BooDog | investorshub | 11/11/2021 4:56:03 PM |
Chart looking good here, easy to goo https://stockcharts.com/h-sc/ui?s=$XSNX | lucky__stock | investorshub | 10/31/2021 12:02:33 PM |
Added here for next week! | lucky__stock | investorshub | 10/31/2021 11:59:30 AM |
Why can't the name Djokovick (although it longer | Q-reus | investorshub | 07/11/2021 7:09:54 PM |
Sounds good | Golden Cross | investorshub | 05/20/2021 11:47:54 AM |
brain salad surgery, maybe. | palacian | investorshub | 05/20/2021 11:23:07 AM |
$XSNX Now pink current | Golden Cross | investorshub | 05/07/2021 8:58:03 AM |
What is this stock attempting to accomplish? I | raisedbywolves1 | investorshub | 02/12/2021 3:47:55 AM |
This one should be higher. It was with | raisedbywolves1 | investorshub | 02/10/2021 5:30:09 AM |
what is it that they do now? are | keatingdemo | investorshub | 12/28/2020 12:03:33 PM |
News, Short Squeeze, Breakout and More Instantly...
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company ...
CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medi...
CLEVELAND, OH / ACCESSWIRE / March 1, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today provided an update on business developments, financing and the 2024 annual meeting. The previously disclosed $10.7 million finan...